1. Bair MJ, Robinson RL, Katon W et al. Depression and pain comorbidity: a
literature review. Arch Intern Med 2003; 163: 2433–45.
2. Carsten E, Voikar V, Rantamaki T. Role of neurotrophic factors in depression.
Curr Opin Pharmacol 2007; 7(1): 18–21.
3. Chen A-H, Shirayama Y, Shin KH et al. Expression of the cAMP response
element binding protein (CREB) in hippocampus produces antidepressant
effect. Biol Psychiatry 2001; 49: 753–62.
4. Duman R, Heninger GR, Nestler EJ. A molecular and cellular theory of
depression. Arch Gen Psychiatry 1997; 54: 597–606.
5. Duman R, Malberg J, Nakagawa S, D'Sa C. Neuronal plasticity and survival
in mood disorders. Biol Psychiatry 2000; 48: 732–9.
6. Duric V, McCarson KE. Persistent pain produces stress-like alterations in
hippocampal neurogenesis and gene expression. J Pain 2006; 7(8): 544–555.
7. ESEMeD/MHEDEA 2000 Investigators. Disability and Quality of life
impact of mental disorders in Europe: Results fr om the European Study of
the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr
Scand 2004; 109(Suppl. 1): 47–54.
8. Gerber PD, Barrett JE, Barrett JA et al. The relashionship of presenting
physical complaints to depressive symptoms in primary care patients. J Gen Intern Med 1992; 7: 170–3.
9. Hamilton M. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 1989; 154: 201–6.
10. Katon WJ, Unutzer J, Silmon G. Treatment of depression in primary
care. Where we are, wh ere we go. Med Care 2004; 42: 1153–7.
11. Kirmayer LJ, Robbins JM, Dworkin M et al. Somatisation and the recognition
of depression and anxiety in primary care. Am J Psychiatry 1993; 150: 734–41.
12. Kroenke K. Somatic symptoms and depression: a double hurt. Prim
Care Companion J Clin Psychiatry 2005; 7: 148–9.
13. Kuipers SD, Bramham CR. Brain-derived neurotrophic factor mechanisms
and function in adult synaptic plasticity: New insights and implications
for therapy. Curr Opin Drug Discov Devel 2006; 9: 580–6.
14. Lemaire V, Koel M, Lemoal M. Prenatal stress produces learning deficits
associated with an inhibition of neurogenesis in the hippocampus. Proc Natl Acad Sci USA 2000; 97: 11032–7.
15. Maier W, Falkai P. The epidemiology of comorbidity between depression,
anxiety disorders and somatic diseases. Int Clin Psychopharmacol 1999; 14(Suppl. 2): 1–6.
16. McEwen B. Stress and hippocampal plasticity. Curr Opin Neurobiol 1999; 5: 205–16.
17. McEwen BS. Mood disorders and allostatic load. Biol Psychiatry 2003; 54: 200–7.
18. Nemeroff CB, Vale WW. The neurobiology of depression: inroads to
treatment and new drug discovery. J Clin Psychiatry 2005; 66(Suppl. I): 5–13.
19. Ohayon MM, Schatzberg AF. Using chronic pain to predict depressive
morbidity in the general population. Arch Gen Psychiatry 2003; 60: 39–47.
20. Pollock K, Grime J. Patients' perception of entitlement to time in general
practice consultations for depression: qualitative study. NMJ 2002; 325: 687.
21. Schuyler D. Depression comes in many disguises to the providers of primary
care: recognition and management. J Med Assoc 2000; 96: 267–75.
22. Sheline Y, Gado MH, Kraemer HC. Untreated depression and hippocampal
volume loss. Am J Psychiatry 2003; 160: 1–3.
23. Shelton RC. The molecular neurobiology of depression. Psychiatr Clin North Am 2007; 30(1): 1–11.
24. Silberstein B. Gender differences in the prevalence of somatic versus
pure depression: a replication. Am J Psychiatry 2002; 159: 1051–2.
25. Stahl SM. The psychopharmacology of painfull physical symptoms in
depression. J Clin Psychiatry 2002: 63–5.
26. Stahl SM, Briley M. Understanding pain in depression. Hum Pharmacol
Clin Exp 2004; 19: 9–13.
27. Stahl SM. Essential Psychopharmacology. Neuroscientific Basis and
Practical Applications. Cambridge University Press, 2005: 135–98.
28. Tylee A, Gastpar M, Lepine JP et al. DEPRES II (Depression research in
European society II): a patient survey of symptoms, disability, and current
management of depression in community. DEPS Steering Committee. Int
Clin Psychopharmacol 1999; 14: 139–51.
29. Tylee A, Gandri P. The importance of somatic symptoms in depression
in primary care. Prim Care Companion J Clin Psychiatry 2005; 7: 167–76.
30. Yoshimura R, Mitoma M, Sugita A et al. Effects of paroxetine or milnacipran
on serum brain-derived neurotrophic factor in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(5): 1034–7.